Who is excited for WOTY West? In addition to watching the HBA's Woman of the Year (WOTY) celebration via telecast from New York, the HBA San Francisco chater also presents guest speakers at WOTY West to be held at Genentech USA Inc. in South San Francisco. Please welcome Jennifer Cook, senior VP of immunology and ophthalmology, Genentech and Michelle Rohrer, senior VP of US regulatory affairs, Genentech.
Jennifer Cook is the senior vice president of immunology and ophthalmology at Genentech. In this role, she is responsible for all US sales and marketing activities for various franchises. Jennifer first joined Genentech in 1987 as a research associate, participating in the development of numerous products in the cardiovascular research and pharmacokinetics and metabolism groups. In 1992, she joined a San Diego-based biotechnology start-up, where she coordinated pre-clinical development of the company’s lead compound in oncology, ophthalmology, and cardiovascular indications. In 1997, Jennifer returned to Genentech and held positions of increasing responsibility over the next nine years in commercial operations, culminating in her role to vice president, market development. In this role, she led market research and forecasting, sales operations, communications, and various other departments. Jennifer was then named vice president of product portfolio management where she was responsible for the project team system, project leadership, and portfolio governance for the Genentech pipeline. In 2009, Jennifer was appointed senior vice president of global portfolio management in the pharma medicines group for Roche. In this role, she is responsible for managing the Roche-Genentech combined pipeline and the global commercial business planning process. Jennifer received her BA in human biology and MS in biology from Stanford University as well as an MBA from the Haas School of Business at University of California, Berkeley. In 2012, the San Francisco Business Times named Jennifer as one of the Bay Area’s “Most Influential Women In Business.”
Michelle Rohrer received her BS, MS and PhD from the University of California, Davis (UCD). As a PhD student in nutrition science with a minor in physiological biochemistry, her thesis focused on the effect of diabetes, obesity and AIDS on trace element metabolism. At that time, Michelle, licensed as a registered dietitian, volunteered at the UC Davis Medical Center counseling patients. Michelle joined Genentech 20 years ago as a post-doctoral research fellow. Starting in 2011, Michelle led the Genentech team that took the unprecedented step of choosing to have an FDA hearing to advocate for the continued approval of Avastin for the treatment of metastatic breast cancer. In 2012, Michelle was selected to be the South San Francisco site head for Roche’s global product development organization and now heads its Leadership Team and is accountable for building and maintaining a strong community for employees. Michelle enjoys writing to inspire others and regularly blogs about life and work.